Mercedes López

Prolonged Survival of Dendritic Cell–Vaccinated Melanoma Patients Correlates With Tumor-Specific Delayed Type IV Hypersensitivity Response and Reduction of Tumor Growth Factor β-Expressing T Cells

Mercedes López, Cristián Pereda, Gabriela Segal et al. · Journal of Clinical Oncology · 2009 · 129 citations · Full text

Life Sciences, Immunology, Oncology +17

Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients

Bárbara Pesce, Lilian Soto, Francisca Sabugo et al. · Clinical & Experimental Immunology · 2012 · 127 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker

Flavio Salazar‐Onfray, Mercedes López, Andreas Lundqvist et al. · British Journal of Cancer · 2002 · 122 citations · Full text

Medicine, Immunology, Oncology +17

Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients

Alejandro Escobar, Mercedes López, Antonio E. Serrano et al. · Clinical & Experimental Immunology · 2005 · 103 citations · Full text

Medicine, Immunology, Oncology +15

Functional Gap Junctions Facilitate Melanoma Antigen Transfer and Cross-Presentation between Human Dendritic Cells

Ariadna Mendoza‐Naranjo, Pablo J. Sáez, C. Christian Johansson et al. · The Journal of Immunology · 2007 · 98 citations · Full text

Life Sciences, Immunology, Oncology +17